
About E-Derma Pharma India Private Limited.
Data last updated:
E-Derma Pharma India Private Limited. is a private limited company based in Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 March 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24234HR2006PTC036078. Its GSTIN is 06AABCE5978P1ZX (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hema Dawar and Raj Narayan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1052 Sec – 12 HUDA Panipat 132103, Haryana, India.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.27 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹27.85 Lakh (net margin 3.8%) and EBITDA of ₹1.23 Cr (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website edermapharma.com.
Company details
Contact details
E-Derma Pharma India Private Limited.'s registered office is in Haryana. Its website is edermapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1052 Sec – 12 HUDA Panipat 132103, Haryana, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of E-Derma Pharma India Private Limited., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of E-Derma Pharma India Private Limited.
FY 2024 filings availableE-Derma Pharma India Private Limited. reported revenue of ₹7.27 Cr (up 14% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 14% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.27 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.9% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of E-Derma Pharma India Private Limited., buy the company report.
Board of directors of E-Derma Pharma India Private Limited.
E-Derma Pharma India Private Limited has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hema Dawar Also directs: Dezra Genesis LLP | Director | 15 Mar 2006 | 20 Years 7 Months | Current |
| Raj Narayan Also directs: Dezra Genesis LLP | Director | 15 Mar 2006 | 20 Years 7 Months | Current |
Auditor
E-Derma Pharma India Private Limited. is audited by ATUL CHOPRA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL CHOPRA & CO. | FY 2023 | 012289N |
Shareholding
The shareholding of E-Derma Pharma India Private Limited. is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of E-Derma Pharma India Private Limited., buy the company report.
Legal cases
No court or tribunal cases involving E-Derma Pharma India Private Limited. are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
E-Derma Pharma India Private Limited. has 6 MSME Form 1 returns on record between 2016 and 2019, listing 19 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Devbhoomi Pharmaceuticals | |||
| BCL Pharma | |||
| Jineka Healthcare Private Limited | |||
| an individual supplier | |||
| Optimus Pharma Private Limited |
To see the full MSME payment records of E-Derma Pharma India Private Limited., buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
E-Derma Pharma India Private Limited has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCE5978P1ZX | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of E-Derma Pharma India Private Limited., buy the company report.
Recent activity
E-Derma Pharma India Private Limited. has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Asha Devi ceased to be Additional Director on 27 Jan 2023.
Frequently asked questions
E-Derma Pharma India Private Limited is an active private limited company based in Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 March 2006 (20+ years old) and is registered under CIN U24234HR2006PTC036078.
E-Derma Pharma India Private Limited has 2 current directors:
- Hema Dawar - Director
- Raj Narayan - Director
The latest financial statements of E-Derma Pharma India Private Limited on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of E-Derma Pharma India Private Limited is 06AABCE5978P1ZX, registered in Haryana.
The CIN (Corporate Identification Number) of E-Derma Pharma India Private Limited is U24234HR2006PTC036078. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
E-Derma Pharma India Private Limited was incorporated on 06 March 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Asha Devi ceased to be Additional Director on 27 Jan 2023. Tikam Chand ceased to be Additional Director on 27 Jan 2023. Hema Dawar was appointed as Director on 15 Mar 2006. E-Derma Pharma India Private Limited has 4 board changes on record in total.
E-Derma Pharma India Private Limited has 6 MSME Form 1 returns on record between 2016 and 2019, listing 19 overdue payments to 13 micro and small suppliers. The latest return was filed on 08 Jun 2019.
E-Derma Pharma India Private Limited can be reached through the website edermapharma.com. Its registered office is in Haryana, India.
The registered office of E-Derma Pharma India Private Limited is at 1052 Sec – 12 HUDA Panipat 132103, Haryana, India.
E-Derma Pharma India Private Limited operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

